Paradeep Phosphates FY26 PAT jumps 52%, shares rise

Paradeep Phosphates shares climbed 6.20% to ₹130.20 after the fertiliser maker reported a strong jump in FY26 profitability, supported by higher sales volumes and operational efficiencies. The company’s audited results were approved at a Board meeting on May 11, 2026, for the quarter and year ended March 31, 2026. The financial update also included a dividend recommendation and governance decisions.

The performance comes at a time when fertiliser manufacturers are focusing on product mix, backward integration, and efficiency improvements to protect margins amid global volatility in raw material markets.

Stock reaction and what drove sentiment

The immediate market response followed the company’s disclosure of higher revenue and sharply improved profits for FY26. The move to ₹130.20 reflected investor focus on full-year earnings momentum rather than the softer Q4 profit trend. The company also highlighted volume-led growth, with value-added NPK grades contributing materially.

In addition to earnings, expansion updates around sulphuric acid and phosphoric acid capacity were part of the narrative. Capacity-linked projects matter for phosphatic fertiliser makers because integration can influence input costs and supply security.

FY26 financial performance: revenue and profit surge

For FY26, revenue from operations increased 28.70% year-on-year to ₹21,826.34 crore from ₹16,958.65 crore in FY25. EBITDA rose 33% year-on-year to ₹2,259 crore, indicating improved operating performance at scale.

Profit before tax (PBT) rose 45.79% to ₹1,327.96 crore from ₹910.87 crore. Reported profit after tax (PAT) for FY26 was close to ₹1,000 crore across disclosures: one set of numbers showed PAT up 50.48% to ₹996.35 crore (from ₹662.13 crore), while another audited standalone figure showed net profit at ₹996.84 crore (from ₹662.85 crore).

Total income for the year was reported at ₹21,972.92 crore compared with ₹17,106.69 crore in the prior year.

Q4 FY26: profit pressure despite higher income

For Q4 FY26, the company reported revenue of ₹4,702 crore, EBITDA of ₹484 crore, PBT of ₹202 crore, and PAT of ₹161 crore.

Separately, a consolidated quarterly update indicated a 9.63% decline in net profit to ₹155.60 crore, compared with ₹172.19 crore a year earlier, citing elevated expenses. In the same update, total income for the January to March quarter rose to ₹4,701.97 crore from ₹4,193.96 crore, while total expenses increased to ₹4,541.51 crore from ₹4,015.30 crore.

The quarter’s numbers underline that cost and expense movements can materially affect profits even when topline growth remains intact.

Volumes and product mix: value-added grades lead growth

Operationally, production volumes rose 8% year-on-year to 36.66 lakh metric tonnes in FY26, while sales volumes increased 10% to 42.10 lakh metric tonnes.

Growth was led by value-added NPK grades. NPK sales including TSP rose 22% year-on-year to 24.64 lakh metric tonnes. The company also cited its distribution reach, noting a network spanning 18 states.

A separate operational disclosure said fertiliser production in FY26 reached 3.67 million metric tonnes per annum, translating to nearly 100% capacity utilisation.

Capacity additions: sulphuric acid and phosphoric acid projects

During FY26, Paradeep Phosphates commissioned sulphuric acid plants at Paradeep and Mangalore. The Paradeep plant was stated at 5,00,000 MTPA and Mangalore at 1,00,000 MTPA. Together, these additions increased total sulphuric acid capacity by 0.6 million metric tonnes per annum, representing a 45% increase in capacity.

On phosphoric acid, the company said its plan to double capacity from 0.5 MMTPA to 1.0 MMTPA is on track. Phase I expansion from 0.5 MMTPA to 0.7 MMTPA is underway and is expected to be commissioned in FY27.

Corporate actions and governance updates

The Board recommended a dividend of ₹1.50 per share. It also approved the re-appointment of Mrs. Rita Menon as Independent Director for a second term.

The company said the audited results were reviewed by M/s BSR & Co. LLP with an unmodified opinion.

Merger context: MCFL integration and reporting base

The company flagged that results were supported by the merger of Mangalore Chemicals and Fertilizers Limited (MCFL), effective from the appointed date of April 1, 2024. This integration is relevant for investors assessing comparability of growth rates and the expanded manufacturing footprint.

Paradeep Phosphates operates facilities in Odisha, Goa and Karnataka, with annual fertiliser production capacity of 3.7 million metric tonnes.

Key numbers at a glance

Market impact: what changed for investors

The headline driver for the stock was the FY26 profit expansion, with PAT reported near ₹1,000 crore and PBT at ₹1,327.96 crore, alongside a revenue base of ₹21,826.34 crore. The dividend recommendation of ₹1.50 per share added a tangible shareholder return signal.

Operational updates also mattered, including the 45% increase in sulphuric acid capacity through a 0.6 MMTPA addition and the visibility on FY27 commissioning for Phase I phosphoric acid expansion to 0.7 MMTPA. The reported volumes and higher NPK and TSP sales reinforced the product-mix theme.

Analysis: why the FY26 result matters

The FY26 result points to a combination of scale and product mix benefits, with revenue rising 28.70% and EBITDA up 33%. Volumes also moved higher, with sales up 10% and value-added NPK (including TSP) up 22%, indicating that growth was not purely price-led.

At the same time, Q4 profit softness, attributed to higher expenses in consolidated reporting, highlights that quarterly earnings can remain sensitive to cost cycles. For a phosphatic fertiliser player, the execution of backward integration projects like sulphuric acid and phosphoric acid capacity expansions is closely watched because these inputs are central to manufacturing economics.

Conclusion

Paradeep Phosphates’ FY26 earnings showed a sharp year-on-year improvement, with revenue from operations at ₹21,826.34 crore and PAT reported around ₹1,000 crore, while volumes and value-added NPK sales grew at a faster clip. The company also outlined capacity additions completed in FY26 and a Phase I phosphoric acid expansion expected to be commissioned in FY27, alongside a ₹1.50 per share dividend recommendation.